Bolt Biotherapeutics Delisted from Nasdaq
Ticker: BOLT · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1641281
| Field | Detail |
|---|---|
| Company | Bolt Biotherapeutics, Inc. (BOLT) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-governance
TL;DR
Bolt Biotherapeutics got kicked off Nasdaq, filing 8-K on 6/6/25.
AI Summary
Bolt Biotherapeutics, Inc. filed an 8-K on June 6, 2025, to report its delisting from the Nasdaq Capital Market due to failure to meet continued listing standards. The company also amended its Articles of Incorporation and Bylaws. Bolt Biotherapeutics, Inc. was formerly known as Bolt Therapeutics, Inc. and changed its name on May 4, 2015.
Why It Matters
This filing indicates that Bolt Biotherapeutics is no longer listed on a major stock exchange, which can significantly impact its ability to raise capital and its stock's liquidity.
Risk Assessment
Risk Level: high — Delisting from a major exchange like Nasdaq is a significant negative event that severely impacts a company's financial standing and investor confidence.
Key Players & Entities
- Bolt Biotherapeutics, Inc. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange from which delisted
- June 6, 2025 (date) — Date of filing and delisting event
- Bolt Therapeutics, Inc. (company) — Former company name
- May 4, 2015 (date) — Date of name change
FAQ
What is the primary reason for Bolt Biotherapeutics' 8-K filing on June 6, 2025?
The primary reason is the company's delisting from the Nasdaq Capital Market due to failure to satisfy continued listing standards.
What other corporate actions are reported in this 8-K filing?
The filing also reports amendments to the company's Articles of Incorporation and Bylaws.
When did Bolt Biotherapeutics change its name?
Bolt Biotherapeutics, Inc. changed its name from Bolt Therapeutics, Inc. on May 4, 2015.
What is the principal executive office address for Bolt Biotherapeutics, Inc.?
The principal executive offices are located at 900 Chesapeake Drive, Redwood City, California 94063.
What is the Commission File Number for Bolt Biotherapeutics, Inc.?
The Commission File Number for Bolt Biotherapeutics, Inc. is 001-39988.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Bolt Biotherapeutics, Inc. (BOLT).